Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001104659-21-142724
Filing Date
2021-11-23
Accepted
2021-11-23 06:02:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A tm2129361d12_sc14d9a.htm SC 14D9/A 29035
  Complete submission text file 0001104659-21-142724.txt   30806
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filed by) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88106 | Film No.: 211434606
SIC: 2834 Pharmaceutical Preparations